206 related articles for article (PubMed ID: 29786187)
1. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
Tatangelo P; Londrino F; Di Vasta G; Guido G; Centi A; Dominijanni S; Bernabei E; Caramiello MS; Di Franco D; Palumbo R
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786187
[TBL] [Abstract][Full Text] [Related]
2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Kuhn C; Kuhn A; Markau S; Kästner U; Osten B
J Clin Apher; 2006 Dec; 21(4):266-70. PubMed ID: 17120233
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.
Vécsei AK; Müller T; Schratzberger EC; Kircher K; Regele H; Arbeiter K; Schroth B; Aufricht C
Pediatr Nephrol; 2001 Nov; 16(11):898-900. PubMed ID: 11685597
[TBL] [Abstract][Full Text] [Related]
5. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
6. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
Soliman AR; Maamoun H; Soliman H; Ahmed RM
Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
[No Abstract] [Full Text] [Related]
7. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
Hogan J; Radhakrishnan J
Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
[TBL] [Abstract][Full Text] [Related]
8. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
9. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
10. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in treatment of collapsing FSGS-A case series.
Girimaji N; Bharati J; Nada R; Rathi M; Kohli HS; Ramachandran R
Nephrology (Carlton); 2021 Feb; 26(2):134-141. PubMed ID: 32662534
[TBL] [Abstract][Full Text] [Related]
13. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
Jayaraman VK; Thomas M
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26887886
[TBL] [Abstract][Full Text] [Related]
14. Therapy-resistant focal and segmental glomerulosclerosis.
Kveder R
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v34-7. PubMed ID: 12817066
[TBL] [Abstract][Full Text] [Related]
15. Treatment of FSGS in Children.
Sethna CB; Gipson DS
Adv Chronic Kidney Dis; 2014 Mar; 21(2):194-9. PubMed ID: 24602468
[TBL] [Abstract][Full Text] [Related]
16. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
[TBL] [Abstract][Full Text] [Related]
17. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
Hansrivijit P; Ghahramani N
Int Urol Nephrol; 2020 Jul; 52(7):1377-1387. PubMed ID: 32306197
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
Usta M; Ersoy A; Dilek K; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
J Intern Med; 2003 Mar; 253(3):329-34. PubMed ID: 12603500
[TBL] [Abstract][Full Text] [Related]
19. Other immunosuppressive agents for focal segmental glomerulosclerosis.
Ponticelli C; Passerini P
Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585
[TBL] [Abstract][Full Text] [Related]
20. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
Hubsch H; Montané B; Abitbol C; Chandar J; Shariatmadar S; Ciancio G; Burke G; Miller J; Strauss J; Zilleruelo G
Pediatr Nephrol; 2005 Feb; 20(2):210-6. PubMed ID: 15605284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
